1. Home
  2. IVDA vs DCOY Comparison

IVDA vs DCOY Comparison

Compare IVDA & DCOY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iveda Solutions Inc.

IVDA

Iveda Solutions Inc.

N/A

Current Price

$0.31

Market Cap

3.7M

Sector

Technology

ML Signal

N/A

Logo Decoy Therapeutics Inc. Common Stock

DCOY

Decoy Therapeutics Inc. Common Stock

N/A

Current Price

$1.85

Market Cap

3.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
IVDA
DCOY
Founded
2003
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.7M
3.2M
IPO Year
2015
2014

Fundamental Metrics

Financial Performance
Metric
IVDA
DCOY
Price
$0.31
$1.85
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
311.9K
★ 3.8M
Earning Date
11-13-2026
11-16-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 51.38
N/A
EPS
★ N/A
N/A
Revenue
★ $4,468,279.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$20.42
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 132.98
N/A
52 Week Low
$0.21
$0.53
52 Week High
$2.15
$13.51

Technical Indicators

Market Signals
Indicator
IVDA
DCOY
Relative Strength Index (RSI) 48.72 33.78
Support Level $0.27 $0.61
Resistance Level $0.33 $3.29
Average True Range (ATR) 0.02 0.70
MACD 0.00 -0.06
Stochastic Oscillator 34.02 1.22

Price Performance

Historical Comparison
IVDA
DCOY

About IVDA Iveda Solutions Inc.

Iveda Solutions Inc offers smart city technologies globally, offering AI-driven video surveillance solutions and a robust suite of Internet of Things (IoT) platforms that power digital transformation for cities and commercial clients. The company offers AI-intelligent video search, smart utility, smart sensors, gateways, and trackers, and IoT platforms (Products). Geographically, the company operates in USA and Taiwan, majority of its revenue is generated from Taiwan.

About DCOY Decoy Therapeutics Inc. Common Stock

Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.

Share on Social Networks: